Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
DRUG compared with BIOA: revenue, margins and what each company keeps, and the suppliers and customers both name
DRUG
Bright Minds Biosciences Inc.
Change
Mkt cap
Revenue
Revenue
BIOA
BioAge Labs, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
DRUG
Bright Minds Biosciences Inc.
vs
BIOA
BioAge Labs, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
DRUG: latest quarter not drawable. BIOA: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only DRUG
11
—
Gerep Realty
unlisted
supplier
—
Technology Innovation Center
unlisted
supplier
—
ZoE Life Fulton Labs Incubator
unlisted
supplier
—
Dr. Cunningham lab
unlisted
supplier
7 more · DRUG chain
›
Shared
0
No disclosed counterparties: BIOA.
Only BIOA
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
DRUG, solid
BIOA, dashed
DRUG
Bright Minds Biosciences Inc.
Change
27.26
▼
−50.41%
· post 24.99
Mkt cap
$200.1M
Revenue
—
Revenue
—
BIOA
BioAge Labs, Inc.
Change
5.81
▼
−0.94%
· post 5.88
Closed
Nov 2 '26
Mkt cap
$260.1M
Revenue
$2M
Q2 FY26
Revenue
$9M
FY25
vs
Compare
Closed
Nov 2 '26
DRUG
Bright Minds Biosciences Inc.
vs
BIOA
BioAge Labs, Inc.
27.26
▼
−50.41%
post 24.99
Price
5.81
▼
−0.94%
post 5.88
$200.1M
Mkt cap
$260.1M
—
Revenue
$2M
Q2 FY26
—
Revenue
$9M
FY25
Change
Change
DRUG
27.26
▼
−50.41%
vs
BIOA
5.81
▼
−0.94%
Closed
Nov 2 '26